Long-acting injectable antiretroviral therapy for HIV-1 infection in adults

被引:0
|
作者
Halani, Sheliza [1 ]
Tan, Darrell [1 ,2 ]
Andany, Nisha [3 ]
机构
[1] Univ Toronto, Dept Med, Toronto, ON, Canada
[2] St Michaels Hosp, Div Infect Dis, Toronto, ON, Canada
[3] Sunnybrook Hlth Sci Ctr, Div Infect Dis, Toronto, ON, Canada
关键词
D O I
10.1503/cmaj.231498
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E341 / E342
页数:2
相关论文
共 50 条
  • [21] Considerations for long-acting antiretroviral therapy in older persons with HIV
    OShea, Jesse G.
    Cholli, Preetam
    Heil, Emily L.
    Buchacz, Kate
    AIDS, 2023, 37 (15) : 2271 - 2286
  • [22] Cabotegravir long-acting for HIV-1 prevention
    Andrews, Chasity D.
    Heneine, Walid
    CURRENT OPINION IN HIV AND AIDS, 2015, 10 (04) : 258 - 263
  • [23] A Conjoint Analysis of the Acceptability of Targeted Long-Acting Injectable Antiretroviral Therapy Among Persons Living with HIV in the US
    Simoni, Jane M.
    Tapia, Kenneth
    Lee, Sung-Jae
    Graham, Susan M.
    Beima-Sofie, Kristin
    Mohamed, Zahra H.
    Christodoulou, Joan
    Ho, Rodney
    Collier, Ann C.
    AIDS AND BEHAVIOR, 2020, 24 (04) : 1226 - 1236
  • [24] Multisite Study of Women Living With HIV's Perceived Barriers to, and Interest in, Long-Acting Injectable Antiretroviral Therapy
    Philbin, Morgan M.
    Parish, Carrigan L.
    Kinnard, Elizabeth N.
    Reed, Sarah E.
    Kerrigan, Deanna
    Alcaide, Maria L.
    Cohen, Mardge H.
    Sosanya, Oluwakemi
    Sheth, Anandi N.
    Adimora, Adaora A.
    Cocohoba, Jennifer
    Goparaju, Lakshmi
    Golub, Elizabeth T.
    Fischl, Margaret
    Metsch, Lisa R.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2020, 84 (03) : 263 - 270
  • [25] Reassessing oral lead-in for injectable long-acting HIV therapy
    Llibre, Josep M.
    Sax, Paul E.
    LANCET HIV, 2021, 8 (11): : E660 - E661
  • [26] Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda
    Zakumumpa, Henry
    Alinaitwe, Adolf
    Kyomuhendo, Marjorie
    Nakazibwe, Brenda
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [27] French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults
    Hoen, Bruno
    Bonnet, Fabrice
    Delaugerre, Constance
    Delobel, Pierre
    Goujard, Cecile
    L'Henaff, Marianne
    Persiaux, Renaud
    Rey, David
    Rouzioux, Christine
    Taburet, Anne-Marie
    Morlat, Philippe
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17
  • [28] Long-Acting Injectable Drugs for HIV-1 Pre-Exposure Prophylaxis: Considerations for Africa
    Moyo, Enos
    Murewanhema, Grant
    Musuka, Godfrey
    Dzinamarira, Tafadzwa
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2022, 7 (08)
  • [29] Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection
    Orkin, Chloe O. C.
    Arasteh, Keikawus A. K.
    Hernandez-Mora, M. Gorgolas M. G. H. M.
    Pokrovsky, Vadim P. V.
    Overton, Edgar T. O. E. T.
    Girard, Pierre-Marie G. P. M.
    Oka, Shinichi O. S.
    Walmsley, Sharon W. S.
    Bettacchi, Chris B. C.
    Brinson, Cynthia B. C.
    Philibert, Patrick P. P.
    Lombaard, Johan L. J.
    Clair, Marty C. M.
    Crauwels, Herta C. H.
    Ford, Susan L. F. S. L.
    Patel, Parul P. P.
    Chounta, Vasiliki C. V.
    D'Amico, Ronald D. R.
    Vanveggel, Simon V. S.
    Dorey, David D. D.
    Cutrell, Amy C. A.
    Griffith, Sandy G. S.
    Margolis, David A. M. D. A.
    Williams, Peter E. W. P. E.
    Parys, Wim P. W.
    Smith, Kimberly Y. S. K. Y.
    Spreen, William R. S. W. R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (12): : 1124 - 1135
  • [30] Compassionate use of long-acting cabotegravir plus rilpivirine for people living with HIV-1 in need of parenteral antiretroviral therapy
    D'Amico, Ronald
    Gomis, Santiago Cenoz
    Moodley, Riya
    Van Solingen-Ristea, Rodica
    Baugh, Bryan
    Van Landuyt, Erika
    Van Eygen, Veerle
    Min, Sherene
    Cutrell, Amy
    Foster, Caroline
    Chilton, Daniella
    Allard, Sabine D.
    Ruiter, Annemiek
    HIV MEDICINE, 2023, 24 (02) : 202 - 211